SynthesisInternational journal of clinical oncology2022

Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.

Takafumi Yanagisawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.